CREG Antibody (299133)

Overexpression of cellular repressor of E1A-stimulated genes (CREG) promotes the proliferation of human umbilical vein endothelial cells (HUVEC). (A) HUVECs infected with adenoviruses carrying CREG-IRES-GFP or GFP, respectively, have a similar infective efficiency. Images were taken by phase contrast microscope (a,c) and by fluorescence microscope (b,d) 48 h after infection. Bar = 25 μm; (B) CREG expression was detected by Western blotting. Levels of CREG were assessed after normalization to beta -tubulin. Data are given as the mean ± SD (n = 3). **p < 0.01 compared with uninfected HUVEC and HUVEC-expressing GFP (AdGFP) control groups. NS: no significant difference; (C) Growth curves of HUVECs, HUVEC-overexpressing CREG (AdCREG) and HUVEC-AdGFP were constructed by plotting cell numbers counted by hemocytometer over three days of incubation. **p < 0.01 compared with uninfected HUVEC and HUVEC-AdGFP control groups. Data are given as the mean ± SD (n = 3). (D) Flow cytometry (FCM) analysis of the cell cycle distributions of cells in three groups. Levels of proliferative potential were accessed by the percentage of cells in the (S + G2) phases of the cell cycle. ***p < 0.001 compared with HUVEC and HUVEC-AdGFP groups. NS: no significant difference. Data are given as the mean ± SD (n = 3). (E) 5-bromo-2′-deoxy-uridine (BrdU) incorporation assay of cells stained positively by diaminobenzidine (DAB) staining solution. The upper panel is a four-times high magnification image of the framed part in the lower panel. Levels of proliferation were assessed by the ratio of average BrdU positive cells to total cells in five random high-magnification fields. Data are given as the mean ± SD (n = 3). * p < 0.05 compared with HUVEC and HUVEC-AdGFP groups. NS: no significant difference. Bar = 25 μm. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/24018888), licensed under a CC-BY license. Not internally tested by R&D Systems.

Downregulation of CREG suppresses the proliferation of HUVEC. (A) Stable HUVEC clones with CREG silenced down (H–S) or expressing a scrambled negative control shRNA sequence (scramble) were established by retroviral infection and puromycin selection. Cell lysates were collected, and the expression of CREG was detected by Western blotting with beta -tubulin used as a loading control; (B) Pooled analysis of CREG protein levels assessed after normalization to CREG/ beta -tubulin of the HUVEC group. Scramble HUVEC were used as a negative control. Data are given as the mean ± SD (n = 3). *p < 0.05; ***p < 0.001; NS: no significant difference; (C) Cell counting by hemocytometer. A total of 2 × 105 cells in the logarithmic phase in each of the three groups were plated in four 10-cm diameter dishes. After 24 h, cells were trypsinized and counted by hemocytometer. **p < 0.01 compared with the HUVEC and scramble group; (D) BrdU incorporation assay. Data are given as the mean ± SD (n = 3). **p < 0.01; ***p < 0.001; NS: no significant difference; (E) Effects of the downregulation of CREG on HUVEC cell cycle progression assessed by FCM; (F) Cell proliferation was accessed by the percentage of (S + G2) phase cells in the cell cycle. Data are given as the mean ± SD (n = 3). **p < 0.01 compared with the HUVEC and scramble group. NS: no significant difference. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/24018888), licensed under a CC-BY license. Not internally tested by R&D Systems.

• Reactivity: Hu
• Applications: WB
• Clone: 299133
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Unconjugated
• Concentration: LYOPH

CREG Antibody (299133) Summary

• Immunogen: Mouse myeloma cell line NS0-derived recombinant human CREG
  Arg32-Gln220
  Accession # O75629
• Specificity: Detects human CREG in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant mouse CREG is observed.
• Source: N/A
• Isotype: IgG2b
• Clonality: Monoclonal
• Host: Mouse
• Gene: CREG1
• Purity Statement: Protein A or G purified from hybridoma culture supernatant

Applications/Dilutions

• Dilutions:
  • Western Blot 1 ug/mL

Packaging, Storage & Formulations

• Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
• Preservative: No Preservative
• Concentration: LYOPH
• Reconstitution Instructions: Reconstitute at 0.5 mg/mL in sterile PBS.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for CREG Antibody (299133)

• cellular repressor of E1A-stimulated genes 1CREG
• cellular repressor of E1A-stimulated genes
• CREG
• CREG1
• protein CREG1

Background

CREG is a secreted glycoprotein that belongs to the CREG protein family. It is induced during differentiation of pluripotent cells and is ubiquitously expressed in adult tissues. Mannose-6 phosphate (M6P) modified CREG binds directly to the M6P/IGF2 receptor to inhibit cell growth (1). Human and mouse CREG share approximately 77% amino acid sequence homology.

1. DiBacco, A. and G. Gill (2003) Oncogene 22:5436.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Publications for CREG Antibody (MAB2380)(1)

Publication using MAB2380

• Han Y, Wu G, Deng J, Tao J, Guo L, Tian X, Kang J, Zhang X, Yan C Cellular repressor of E1A-stimulated genes inhibits human vascular smooth muscle cell apoptosis via blocking P38/JNK MAP kinase activation. J. Mol. Cell. Cardiol., 2010-01-06;48(6):1225-35. 2010-01-06 [PMID: 20060003] (IHC-Fr, Western Blot, Human)

Bioinformatics

• Gene Symbol: CREG1
• Uniprot:
  • O75629()